David Arkowitz Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David Arkowitz.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David Arkowitz. David Arkowitz is a Chief Financial Officer in IDENIX PHARMACEUTICALS INC ($IDIX) and a Chief Financial Officer in Flexion Therapeutics Inc ($FLXN) and a Director in PROTEOSTASIS THERAPEUTICS, INC. ($PTI) and a Director in Spring Bank Pharmaceuticals, Inc. ($SBPH).
Address: C/O IDENIX PHARMACEUTICALS, INC. 60 HAMPSHIRE STREET CAMBRIDGE 02139 MA
Companies in which David Arkowitz is an Insider
F-star Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David Arkowitz: Director
Holdings: 37,929 shares
Current Value: $284,468
Latest Transaction: Jun 07 2021
$SBPH Market Capitalization: $58.25M
$SBPH Previous Close: $7.50
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Flexion Therapeutics Inc
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David Arkowitz: Chief Financial Officer
Holdings: 220,719 shares
Current Value: $4,202,490
Latest Transaction: May 12 2021
$FLXN Market Capitalization: $504.85M
$FLXN Previous Close: $19.04
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IDENIX PHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David Arkowitz: Chief Financial Officer
Holdings: 8,000 shares
Latest Transaction: Mar 14 2007
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
YUMANITY THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of David Arkowitz: Director
Holdings: 4,347 shares
Current Value: $64,683
Latest Transaction: Dec 28 2020
$YMTX Market Capitalization: $367.66M
$YMTX Previous Close: $14.88
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of David Arkowitz
Sentiment: All, SBPH, FLXN, IDIX, YMTX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 07 2021 | SBPH | F-star Therapeutic ... | Arkowitz David | Director | Option Exercise | A | 6.88 | 20,000 | 137,600 | 20,000 | |
| May 12 2021 | FLXN | Flexion Therapeuti ... | Arkowitz David | Chief Financial Off ... | Sell | S | 7.23 | 2,229 | 16,116 | 220,719 | 222.9 K to 220.7 K (-1.00 %) |
| Jan 07 2021 | FLXN | Flexion Therapeuti ... | Arkowitz David | Chief Financial Off ... | Sell | S | 11.13 | 6,073 | 67,592 | 151,048 | 157.1 K to 151 K (-3.87 %) |
| Dec 28 2020 | PTI | YUMANITY THERAPEUT ... | Arkowitz David | Director | Grant | A | 23.00 | 4,347 | 99,981 | 4,347 | 0 to 4.3 K |
| Jul 20 2020 | FLXN | Flexion Therapeuti ... | Arkowitz David | Chief Financial Off ... | Grant | A | 0.00 | 38,750 | 0 | 157,121 | 118.4 K to 157.1 K (+32.74 %) |
| Jul 20 2020 | FLXN | Flexion Therapeuti ... | Arkowitz David | Chief Financial Off ... | Grant | A | 0.00 | 38,750 | 0 | 157,121 | 118.4 K to 157.1 K (+32.74 %) |
| Jul 01 2020 | PTI | PROTEOSTASIS THERA ... | Arkowitz David | Director | Option Exercise | A | 1.39 | 17,400 | 24,186 | 17,400 |